TNF and infection: Patients administered TNF inhibitors for immune-mediated inflammatory disorders are known to be susceptible to infection by diverse opportunistic pathogens, including Coccidioides, Histoplasma, Nontuberculous mycobacteria, and Mycobacterium tuberculosis (Winthrop and Chiller, 2009).